ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
12.90
+0.15 (1.18%)
Oct 15, 2025, 1:37 PM CET
1.18%
Market Cap98.61M
Revenue (ttm)9.40M
Net Income (ttm)-12.69M
Shares Out7.73M
EPS (ttm)-1.64
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,573
Average Volume6,877
Open12.70
Previous Close12.75
Day's Range12.65 - 13.00
52-Week Range5.35 - 31.00
Beta1.06
RSI70.31
Earnings DateNov 6, 2025

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhan... [Read more]

Sector Healthcare
Founded 2000
Employees 10
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.

Financial Statements

News

There is no news available yet.